150 related articles for article (PubMed ID: 12810691)
1. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis.
Hong X; Lei L; Glas R
J Exp Med; 2003 Jun; 197(12):1731-43. PubMed ID: 12810691
[TBL] [Abstract][Full Text] [Related]
2. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.
Gavioli R; Frisan T; Vertuani S; Bornkamm GW; Masucci MG
Nat Cell Biol; 2001 Mar; 3(3):283-8. PubMed ID: 11231578
[TBL] [Abstract][Full Text] [Related]
3. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
5. Proteasomes get by with lots of help from their friends.
Yewdell JW; Princiotta MF
Immunity; 2004 Apr; 20(4):362-3. PubMed ID: 15084265
[TBL] [Abstract][Full Text] [Related]
6. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
7. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
8. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
Bury M; Młynarczuk I; Pleban E; Hoser G; Kawiak J; Wójcik C
Folia Histochem Cytobiol; 2001; 39(2):131-2. PubMed ID: 11374791
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells.
Abe S; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Takizawa T; Kitagawa M
Exp Mol Pathol; 2007 Dec; 83(3):405-12. PubMed ID: 17521628
[TBL] [Abstract][Full Text] [Related]
10. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
11. A giant protease with potential to substitute for some functions of the proteasome.
Geier E; Pfeifer G; Wilm M; Lucchiari-Hartz M; Baumeister W; Eichmann K; Niedermann G
Science; 1999 Feb; 283(5404):978-81. PubMed ID: 9974389
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of muscle cachexia: it may be more than the proteasome.
Hasselgren PO; Wray C; Mammen J
Biochem Biophys Res Commun; 2002 Jan; 290(1):1-10. PubMed ID: 11779124
[TBL] [Abstract][Full Text] [Related]
14. Proteases, proteases and proteases for presentation.
Herberts C; Reits E; Neefjes J
Nat Immunol; 2003 Apr; 4(4):306-8. PubMed ID: 12660727
[No Abstract] [Full Text] [Related]
15. Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors.
Hong X; Lei L; Künert B; Naredla R; Applequist SE; Grandien A; Glas R
Cancer Res; 2007 Aug; 67(15):7165-74. PubMed ID: 17671184
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells.
Dou QP; McGuire TF; Peng Y; An B
J Pharmacol Exp Ther; 1999 May; 289(2):781-90. PubMed ID: 10215653
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the endopeptidase activity of tripeptidyl-peptidase II.
Eklund S; Dogan J; Jemth P; Kalbacher H; Tomkinson B
Biochem Biophys Res Commun; 2012 Aug; 424(3):503-7. PubMed ID: 22771804
[TBL] [Abstract][Full Text] [Related]
18. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]